Elevated systemic interleukin-18 in multiple injured patients is not related to clinical outcome

Journal of Interferon and Cytokine Research

Volumn 28, Issue 12, 2008, Pages 741-747

  Roetman, Bernd ^a   Schinkel, Christian ^a   Wick, Mark ^a   Frangen, Thomas ^a   Muhr, Gert ^a   Köller, Manfred ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; MULTIPLE TRAUMA; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHOOL CHILD; TH1 CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; INJURY SEVERITY SCORE; INTERLEUKIN-18; INTERLEUKIN-4; MALE; MIDDLE AGED; MULTIPLE TRAUMA; YOUNG ADULT;

EID: 57149110622     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0029     Document Type: Article

References (38)

1. Ami K, Kinoshita M, Yamauchi A, Nishikage T, Habu Y, Shinomiya N, Iwai T, Hiraide H, Seki S. 2002. IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in post-burn bacterial infection models and the therapeutic effect of IL-18. J Immunol 169:4437-4442.
2. Cameron LA, Taha RA, Tsicopoulos A, Kurimoto M, Olivenstein R, Wallaert B, Minshall EM, Hamid QA. 1999. Airway epithelium expresses interleukin-18. Eur Respir J 14:553-559.
3. Emmanuilidis K, Weighardt H, Matevossian E, Heidecke CD, Ulm K, Bartels H, Siewert JR, Holzmann B. 2002. Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome. Shock 18:301-305.
4. Furuya D, Yagihashi A, Komatsu M, Masashi N, Tsuji N, Kobayashi D, Watanabe N. 2002. Serum interleukin-18 concentrations in patients with inflammatory bowel disease. J Immunother 25 (Suppl. 1):65-67.
5. Futani H, Okayama A, Matsui K, Kashiwamura S, Sasaki T, Hada T, Nakanishi K, Tateishi H, Maruo S, Okamura H. 2002. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother 25 (Suppl. 1:61-64).
6. Greenspan L, McLellan BA, Greig H. 1985. Abbreviated Injury Scale and Injury Severity Score: a scoring chart. J Trauma 25:60-64.
7. Hirota M, Shibata M, Ogawa M. 2002. Increased concentrations of plasma interleukin-18 in patients with hepatic failure 1 week after surgery. J Immunother 25 (Suppl. 1):75-77.
8. Ikawa K, Nishioka T, Yu Z, Sugawara Y, Kawagoe J, Takizawa T, Primo V, Nikolic B, Kuroishi T, Sasano T, Shimauchi H, Takada H, Endo Y, Sugawara S. 2005. Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice. J Leukoc Biol 78:1118-1126.
9. Ikuta S, Ono S, Kinoshita M, Seki S, Hiraide H, Mochizuki H. 2004. Enhanced interferon-gamma production and bacterial clearance in the liver of splenectomized mice in the models of Escherichia coli injection or intestinal obstruction. Shock 21:452-457.
10. Kabir K, Keller H, Grass G, Minor T, Stueber F, Schroeder S, Putensen C, Paul C, Burger C, Rangger C, Neville LF, Mathiak G. 2003. Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit. Int J Mol Med 12:565-570.
11. Kashiwamura Si, Ueda H, Okamura H. 2002. Roles of interleukin-18 in tissue destruction and compensatory reactions. [Review]. J Immunother 25 (Suppl. 1):4-11.
12. Kawakami K. 2002. Interleukin-18 and host defense against infectious pathogens. [Review]. J Immunother 25 (Suppl. 1):12-19.
13. Kinoshita M, Seki S, Ono S, Shinomiya N, Hiraide H. 2004. Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice. Ann Surg 240:313-320.
14. Kinoshita M, Shinomiya N, Ono S, Tsujimoto H, Kawabata T, Matsumoto A, Hiraide H, Seki S. 2006. Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa. J Immunol 177:4627-4635.
15. Knoferl MW, Liener UC, Perl M, Bruckner UB, Kinzl L, Gebhard F. 2004. Blunt chest trauma induces delayed splenic immunosuppression. Shock 22:51-56.
16. Kuranaga N, Kinoshita M, Kawabata T, Habu Y, Shinomiya N, Seki S. 2006. Interleukin-18 protects splenectomized mice from lethal Streptococcus pneumoniae sepsis independent of interferon-gamma by inducing IgM production. J Infect Dis 194:993-1002.
17. Lotze MT, Tahara H, Okamura H. 2002. Interleukin-18 as a novel, distinct, and distant member of the interleukin-1 family promoting development of the adaptive immune response: The interleukin-18 issue of the Journal of Immunotherapy. [Miscellaneous]. J Immunother 25 (Suppl. 1):1-3.
18. Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, Veit V, Paul P, Rubinstein M, Dinarello CA, Harle JR, Kaplanski G. 2005. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106:3483-3489.
19. Muhl HP, Feilschifter J. 2004. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur J Pharmacol 500:63-71.
20. Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. 1989. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 57:590-595.
21. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. 2001a. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12:53-72.
22. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. 2001b. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474.
23. Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G, Dinarello CA, Rubinstein M. 2001. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 14:334-342.
24. Oberholzer A, Steckholzer U, Kurimoto M, Trentz O, Ertel W. 2001. Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock 16:411-414.
25. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF, Jr., Foley E, Moskaluk CA, Bickston SJ, Cominelli F. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 162:6829-6835.
26. Shibata M, Hirota M, Nozawa F, Okabe A, Kurimoto M, Ogawa M. 2000. Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy. Cytokine 12:1526-1530.
27. Sigal LH. 2005. Basic science for the clinician 34: Interleukins of current clinical relevance (part II). J Clin Rheumatol 11:34-39.
28. Singleton KD, Beckey VE, Wischmeyer PE. 2005. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 24:583-589.
29. Stassen NA, Breit CM, Norfleet LA, Polk HC Jr. 2003. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 134:351-356.
30. Stoll S, Jonuleit H, Schmitt E, Muller G, Yamauchi H, Kurimoto M, Knop J, Enk AH. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 28:3231-3239.
31. Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk AH. 1997. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159:298-302.
32. Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, Hanzawa K, Kumagai K, Okamura H, Takada H. 2001. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 167:6568-6575.
33. Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, Kurimoto M. 1997. Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res 289:499-503.
34. Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T, Okamura H, Nakanishi K. 2000. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 12:151-160.
35. Tschoeke SK, Oberholzer A, Moldawer LL. 2006. Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 34:1225-1233.
36. Udagawa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT. 1997. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185:1005-1012.
37. Ueno N, Kashiwamura S, Ueda H, Okamura H, Tsuji NM, Hosohara K, Kotani J, Marukawa S. 2005. Role of interleukin 18 in nitric oxide production and pancreatic damage during acute pancreatitis. Shock 24:564-570.
38. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161:3400-3407.